Results 201 to 210 of about 238,870 (356)
Circulating biomarkers of infection and endometrial cancer risk. [PDF]
Michels KA +7 more
europepmc +1 more source
This case series evaluated the clinical utility of [99mTc]Tc‐MAG3 renal scintigraphy in managing malignant ureteral obstruction (MUO). Renal scintigraphy‐guided decision‐making allowed safe conservative management in selected patients, particularly those with a non‐functional excretion pattern, and helped avoid unnecessary urinary drainage.
Akira Ohtsu +11 more
wiley +1 more source
IKBKE modulates autophagy and progestin resistance in endometrial cancer. [PDF]
Wang J, Kong X.
europepmc +1 more source
Risk of endometrial cancer in subfertile women undergoing ovarian stimulation
NULL AUTHOR_ID
openalex +2 more sources
Abstract BACKGROUND Plant‐lignans are polyphenols with low bioavailability and bioactivity that are transformed by the intestinal microbiota into enterolignans. Our hypotheses are: (i) the way in which plant‐lignans are ingested in the diet affects, in a decisive way, the microbial metabolism of these compounds and (ii) an increase in lignan ...
Susana Langa +4 more
wiley +1 more source
Dissecting endometrial cancer complexity in response to standard and targeted therapies. [PDF]
Vaccarella S +27 more
europepmc +1 more source
Opportunities to restore sexual function in reproductive-aged women after treatment for endometrial cancer and borderline ovarian tumors [PDF]
А. Е. Солопова +3 more
openalex +1 more source
Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials [PDF]
et al,, Mutch, David G
core +1 more source
ABSTRACT Non‐small cell lung cancer (NSCLC) is the most common type of lung cancer, with a 5‐year survival rate of less than 20% and a high risk of recurrence despite advances in treatment. This study aimed to identify new therapeutic targets to increase the effectiveness of NSCLC treatments.
Rui‐Shi Wei +5 more
wiley +1 more source

